Skip to main content
Clinical Trials/ISRCTN50126981
ISRCTN50126981
Completed
未知

ECHographic technologies for bone fracture risk assessments and better OSteoporosis diagnoses (ECHOS)

niversity Hospital Southampton NHS Foundation Trust0 sites4,307 target enrollmentMarch 2, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
niversity Hospital Southampton NHS Foundation Trust
Enrollment
4307
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/33278653/ primary results to assess the diagnostic accuracy of Radiofrequency Echographic Multi Spectrometry (REMS) technology with respect to DXA (added 06/12/2022)

Registry
who.int
Start Date
March 2, 2020
End Date
December 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospital Southampton NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Attending for DXA scan as part of routine clinical care
  • 2\. Both women and men
  • 3\. All ethnicities
  • 4\. Age range from 30 to 80 years
  • 5\. Body mass index (BMI) \< 40 kg/m2
  • 6\. Absence of significant walking impairment
  • 7\. Medical prescription for a spinal and/or femoral DXA
  • 8\. Signed informed consent

Exclusion Criteria

  • 1\. Must be able to understand information sheet and give informed consent
  • 2\. Significant walking impairment
  • 3\. BMI \> 40 kg/m2

Outcomes

Primary Outcomes

Not specified

Similar Trials